Response to Cornish et al.

American Journal of Gastroenterology

Volumn 104, Issue 2, 2009, Pages 534-535

  Villafruela Cives, M ^a  

^a HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; IMMUNOMODULATING AGENT; INFLIXIMAB; ORAL CONTRACEPTIVE AGENT; CONTRACEPTIVE AGENT;

ADULT; BLOODY DIARRHEA; CASE REPORT; ENTERITIS; FEMALE; HUMAN; LETTER; ORAL CONTRACEPTION; PRIORITY JOURNAL; RISK FACTOR; VAGINA RING; CHEMICALLY INDUCED DISORDER; DRUG CONTRAINDICATION; NOTE; PATHOLOGY; ULCERATIVE COLITIS;

ADULT; COLITIS, ULCERATIVE; CONTRACEPTIVE AGENTS, FEMALE; FEMALE; HUMANS;

EID: 59749086065     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2008.70     Document Type: Letter

References (5)

1. Cornish AJ, Tan E, Simillis C et al. The risk of oral contraceptives in the etiology of inflammatory bowel disease: a meta-analysis. Am J Gastroenterol 2008;103:2394-400.
2. García Rodríguez LA, González-Pérez A, Johansson S et al. Risk factors for inflammatory bowel disease in the general population. Aliment Pharmacol Ther 2005;22:309-15.
3. Green BT, DiPalma AJ.Crohn's disease activity not affected by oral contraceptives. Am J Gastroenterol 2000;95:1585-6.
4. Alic M. Epidemiology supports oral contraceptives as a risk factor in Crohn's disease. Gut 2000;46:140.
5. Godet PG, May GR, Sutherland LR. Meta-analysis of the role of oral contraceptive agents in inflammatory bowel disease. Gut 1995;37:668-73.